Linkage Fengye Capital

The firm invests at the earliest points of company formation, specifically seed and start-up stages. This means it typically writes the first or second institutional check into a company, often before any meaningful revenue traction exists. The strategy differs from growth-stage or pre-IPO funds that dominate China's venture landscape.

No. Based on the firm's public profile and Shanghai headquarters, Linkage Fengye Capital operates exclusively within China's domestic startup ecosystem. This single-market concentration contrasts with cross-border firms that split attention between China, Southeast Asia, and North American deal flow.

Early-stage venture capital in China depends heavily on founder networks, university pipelines, and relationships with corporate research labs. Linkage Fengye Capital's position in Shanghai — a major technology, finance, and higher-education hub — suggests deal flow originates from these local institutional networks as well as founder referrals from existing portfolio companies.

Specific sector preferences have not been publicly disclosed. The firm's mandate as described in available records covers the broader technology and innovation economy in China, suggesting a generalist early-stage approach rather than a thesis-driven vertical focus like deep tech or healthcare exclusively.

The firm's fundraising status and limited partner base are not publicly known. Many China-based early-stage firms operate with a combination of founding partner capital, domestic high-net-worth individuals, and government guidance funds, but no specific LP information has been reported for Linkage Fengye Capital.